IDYA Stock Analysis: Buy, Sell, or Hold?
IDYA - IDEAYA Biosciences, Inc. Common Stock
$29.04
-0.44 (-1.49%)
▼
5d:
-8.77%
30d:
-4.66%
90d:
-16.41%
HOLD
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 05, 2026
5d
Get Alerted When IDYA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IDYA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IDYA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IDYA is currently trading at $29.04, which is considered oversold relative to its 30-day fair value range of $31.03 to $33.34.
Technical Outlook: Technically, IDYA is in a downtrend. The price is currently testing key support at $29.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IDYA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $52.81 (+81.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IDYA is in a downtrend. The price is currently testing key support at $29.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IDYA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $52.81 (+81.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$31.03 -
$33.34
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 81.9% below Wall St target ($52.81)
- CAUTION: 5-day price weakness (-8.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$31.03 -
$33.34
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$29.31
Resistance Level
$34.67
Current Trend
Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.72
Wall Street Target
$52.81
(+81.9%)
Revenue Growth (YoY)
55.4%
Profit Margin
-52.0%
Share & Embed Analysis
Last updated: April 29, 2026 6:53 AM ET
Data refreshes hourly during market hours. Next update: 7:53 AM
Data refreshes hourly during market hours. Next update: 7:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IDYA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jeffrey Stein
BUY
50000 shares
2026-03-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 52 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 60 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 67 BUY |
